The Oxford-AstraZeneca COVID-19 vaccine is being withdrawn worldwide, according to the company.
The announcement comes months after AstraZeneca admitted in court documents that it can cause a rare and dangerous side effect, Reuters is reporting.
“As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
The vaccine can no longer be used in the European Union after the company voluntarily withdrew its “marketing authorization,” according to The Independent.
The company faced a class-action lawsuit that claimed the vaccine caused TTS – which stands for Thrombosis with Thrombocytopenia Syndrome. TTS causes people to have blood clots and a low blood platelet count, according to The Associated Press.
The application to withdraw the vaccine was made on March 5 and went into effect on Tuesday.
Similar applications will be made in …